Trial Profile

A Phase 1, Multicenter, First-in-human Study of DS-1471a In Subjects With Advanced Solid Tumors

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 19 Apr 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs DS 1471 (Primary)
Indications Solid tumours
Focus Adverse reactions; First in man
Sponsors Daiichi Sankyo Company

Most Recent Events

17 Sep 2024 Trial design discussed in an abstract published at 49th European Society for Medical Oncology Congress
04 Sep 2024 According to Daiichi Sankyos media release, the data of this trial will be presented in Daiichi Sankyos Second ADC Platform and DXd ADC Data in Multiple Additional Cancers at ESMO in september
12 Oct 2023 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com